Adlib and Court Square Group Power Up for Innovation With A Fresh Perspective On AI Automation In Life Sciences
At the end of July, Adlib team welcomed our long-time partner and industry expert, Keith Parent, at our Toronto office. Keith Parent is an owner and principal business developer at Court Square Group - an IT Managed Service provider for life science companies, from startup to market leaders, and owner of life science point solution RegDocs365. Headlining the day’s information session, Keith inspired with his passion for innovation via automation of the everyday challenges faced by clinical research associates (CRAs) and trial administrators (CTAs).
Decades of pharmaceutical industry knowledge gathered through deep connections with his customers and industry leaders, along with a thorough understanding of IT infrastructures and ecosystems, give Keith a unique perspective on how to help solve the challenges experienced by the pharma and CRO companies with automation and AI-based solutions.
During the industry overview session, Keith took the Adlib team through the full drug development cycle, from pre-clinical to market launch stages. At each stage, he highlighted and expanded on bottlenecks caused by inefficient and manual document processes that result in FDA approval and product launch delays. A good chunk of our discussion was focused on the clinical stage and the preparation of the Trial Master File.
During the session, we have identified top 5 challenges experienced by the CRAs and CTAs when it comes to TMF management: